Use of Bubble Continuous Positive Airway Pressure Compared to Nasal Prong Oxygen or Humidified High Flow in Children Under Five With Severe Pneumonia and Hypoxaemia
NCT01396759 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 975
Last updated 2015-07-28
Summary
Continuous Positive Airway Pressure (CPAP) is a common form of support for patients admitted to Intensive Care Units (ICUs) of industrialized countries with respiratory distress (1). Nasal CPAP (NCPAP) is effective in correcting hypoxemia and contributes to reducing the number of children requiring endo-tracheal intubation and mechanical ventilation (2). CPAP is most frequently delivered to neonates using conventional mechanical ventilators, and thus there is minimal or no cost saving. There are other ways of delivering CPAP, such as Bubble-CPAP, which requires a source of gas flow (typically 6-8 L/ minute in a neonate), an air-oxygen blender, a humidifier and a T-piece.(3). The expiratory arm is inserted in a bottle of water and the level of CPAP delivered is equivalent to the length of the expiratory tubing that remains under water. Robust equipment is now available at a fraction of the cost of mechanical ventilators. Bubble-CPAP has potential advantages over the mechanical ventilation, such as lower cost, ease of application by nursing staff, lower risk of complications, and has been proposed as an inexpensive method of delivering CPAP in developing countries (3).
High flow air/oxygen mix is useful in reducing the indication of mechanical ventilation (4); however, there is a lack of randomized studies comparing it with bubble CPAP or with standard flow O2 supplementation by nasal prongs. High flow air/oxygen mix uses flows of 2 litre per kg per minute of blended air/oxygen mix, usually with a low fraction of inspired oxygen (say 25-40%). It is easy to apply, but requires additional equipment to standard oxygen therapy, and closer monitoring. "High flow" delivers uncertain levels of CPAP, so it is not clearly superior to bubble-CPAP, and there have been no controlled comparative trials of these two techniques.
Pneumonia and malnutrition are two of the most common co-morbidities in children in developing countries (5). In hospitals in resource-poor settings, children with severe malnutrition and pneumonia often present with respiratory distress with or without severe hypoxaemia and impending respiratory failure (6). They initially receive O2 supplementation through nasal prong or face mask. Support from bubble CPAP might help to effectively treat hypoxaemia, improve respiratory function, avoid the need for mechanical ventilation and its complications, and reduce mortality.
Almost half of the patients admitted in the intensive care unit of the Dhaka hospital of ICDDR,B present with hypoxaemia, many with impending respiratory failure. Children with pneumonia also invariably have severe malnutrition with or without diarrhoea (Chisti MJ, MMed thesis, unpublished data). They often need mechanical ventilation, with attendant costs, complications and high mortality rates. However, no published data are available about the use of bubble-CPAP in children with pneumonia and malnutrition and there have been no controlled trials of CPAP in developing countries.
The Hypothesis is:
In children with severe pneumonia and hypoxaemia the probability of treatment failure (see definition below) will be significantly lower when respiratory support is initially provided by bubble-CPAP or high-flow, humidified air/O2 mix by nasal prongs, compared to standard oxygen flow.
Conditions
- Pneumonia
- Hypoxaemia
Interventions
- PROCEDURE
-
Bubble continuous positive airway pressure
All children will be monitored for by pulse oximetry for arterial O2 saturation, respiratory rate, lower chest wall in-drawing, intercostal retraction, head nodding, cyanosis, tracheal tug, heart failure (defined by the presence of tachypnea, tachycardia, gallop rhythm, hepatomegaly, pedal oedema, basal crackles). Arterial or capillary blood gas analyses will be done for children failing to maintain saturation (\>90% with allocated treatment), or if there is concern about hypercarbia or acidosis.
- PROCEDURE
-
Humidified high flow air / O2 mix at 2 l/kg/min
Humidified high flow air / O2 mix at 2 l/kg/min through nasal canula. All children will be monitored for by pulse oximetry for arterial O2 saturation, respiratory rate, lower chest wall in-drawing, intercostal retraction, head nodding, cyanosis, tracheal tug, heart failure (defined by the presence of tachypnea, tachycardia, gallop rhythm, hepatomegaly, pedal oedema, basal crackles). Arterial or capillary blood gas analyses will be done for children failing to maintain saturation (\>90% with allocated treatment), or if there is concern about hypercarbia or acidosis.
- PROCEDURE
-
Standard O2 supplementation by nasal cannula at 0.5 - 2 l/min
Standard O2 supplementation will be given by nasal cannula at 0.5 - 2 l/min. All children will be monitored for by pulse oximetry for arterial O2 saturation, respiratory rate, lower chest wall in-drawing, intercostal retraction, head nodding, cyanosis, tracheal tug, heart failure (defined by the presence of tachypnea, tachycardia, gallop rhythm, hepatomegaly, pedal oedema, basal crackles). Arterial or capillary blood gas analyses will be done for children failing to maintain saturation (\>90% with allocated treatment), or if there is concern about hypercarbia or acidosis.
Sponsors & Collaborators
-
AusAID
collaborator UNKNOWN - collaborator OTHER
-
International Centre for Diarrhoeal Disease Research, Bangladesh
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Max Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-07-31
- Primary Completion
- 2015-06-30
- Completion
- 2015-06-30
Countries
- Bangladesh
Study Locations
More Related Trials
-
High Flow Nasal Oxygen Therapy in Pediatric Hypercapnic Respiratory Failure During Perioperative Stage
NCT03534960 ·Status: UNKNOWN ·Phase: NA
-
Environmental or Nasal Cannula Oxygen for Preterm Infants Receiving Oxygen Therapy: a Randomized Cross-over Pilot Study
NCT02794662 ·Status: COMPLETED ·Phase: NA
-
CPAP Or Nasal Cannula Oxygen for Preterm Infants: A Randomized Controlled Trial
NCT04792099 ·Status: COMPLETED ·Phase: NA
-
Study of the Effects of CPAP and HHHFNC on Diaphragmatic Dimensions in Preterm Infants
NCT02421328 ·Status: COMPLETED ·Phase: NA
-
Work of Breathing in Bronchiolitis Under Non-invasive Ventilation
NCT04677556 ·Status: COMPLETED ·Phase: NA
-
Optimizing High Flow Nasal Cannula Oxygenation in Pediatric Airway Procedures
NCT06947902 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pilot Study Comparing Different Modes of Non-invasive Ventilation for the Oral Feeding of Preterm Infants
NCT02055339 ·Status: COMPLETED ·Phase: NA
-
Effects of Nasal High Flow Therapy on Ventilation and Gas Exchange in Healthy Newborns
NCT02632825 ·Status: COMPLETED ·Phase: NA
-
Feasibility and Acceptability Followed by Effectiveness of bCPAP for Treatment of Children Aged 1-59 Months With Severe Pneumonia in Ethiopia
NCT03870243 ·Status: COMPLETED ·Phase: NA
-
Continuous Positive Airway Pressure (CPAP) Pediatric Patients With Subglottic Stenosis Who Undergo Balloon Dilatation
NCT06183515 ·Status: COMPLETED ·Phase: NA
-
HFNC Versus NCPAP/ NPPV in Infants With Severe Bronchiolitis
NCT04650230 ·Status: COMPLETED ·Phase: NA
-
Comparison of Oxygen Adminstration by Nasal Cannula and High Flow Cannula During Bronchoscopy
NCT03976167 ·Status: COMPLETED ·Phase: NA
-
Noninvasive Continuous Positive Airway Pressure (NCPAP) in Children
NCT01242150 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Efficacy Study of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age
NCT04264156 ·Status: TERMINATED ·Phase: PHASE2
-
Non-invasive Ventilation for Extubation Success in Infants Less Than 1,250 Grams
NCT02051491 ·Status: UNKNOWN ·Phase: NA
-
Fraction of Oxygen on Induction of Anesthesia in Infants
NCT04722276 ·Status: COMPLETED ·Phase: NA
-
Use of High Flows in Pediatric Cardiac Surgical Patients
NCT01633801 ·Status: UNKNOWN ·Phase: NA
-
High Flow Nasal Cannula Use in Infants With Bronchiolitis
NCT02737280 ·Status: TERMINATED ·Phase: NA
-
Work of Breathing in Nasal CPAP Versus High Flow Nasal Prong in Infants With Severe Acute Bronchiolitis
NCT01944995 ·Status: UNKNOWN ·Phase: NA
-
Bubble Continuous Positive Airway Pressure for Children With Severe Pneumonia in Mali, Africa
NCT03944551 ·Status: TERMINATED ·Phase: NA
-
Efficacy Evaluation of Positive End-expiratory Pressure in Children Undergoing Mechanical Ventilation Using Supraglottic Airway Device
NCT05275283 ·Status: UNKNOWN ·Phase: NA
-
High-flow Nasal Oxygen Therapy in Hospitalized Infant With Moderate-to-severe Bronchiolitis
NCT02856165 ·Status: COMPLETED ·Phase: NA
-
Duration of Continuous Positive Airway Pressure and Pulmonary Function Testing in Preterm Infants
NCT02249143 ·Status: COMPLETED ·Phase: NA
-
High Flow Nasal Cannula for Safe Apnea
NCT04849520 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Efficacy of Oxygen Therapy and Clinical Feasibility of High Flow Nasal Cannula During Moderate and Deep Sedation in Pediatric Patients
NCT04852432 ·Status: RECRUITING ·Phase: NA